Friday, 26 February 2021
No Result
View All Result
eudebates.tv
  • EU Policies
  • World
  • Special Debates
  • Events
  • Vote & Polls
eudebates.tv
No Result
View All Result
Home Debates EU Policies Health

EU negotiates more future Covid-19 vaccine deals

EUdebates Team by EUdebates Team
21/08/2020
in Health
0
Corona Covid Covid-19 Coronavirus Pandemic Vaccine
11
SHARES
106
VIEWS
Share on FacebookShare on Twitter

Related posts

Vaccine against COVID-19

WHO chief urges global leaders: ‘Don’t Undermine COVAX’

25/02/2021
Coronavirus test

Fake negative Covid-19 test certificates sold across Europe

23/02/2021

European Commission has concluded exploratory talks with CureVac to purchase a potential vaccine against COVID-19. This is following the positive steps with Sanofi-GSK on 31 July and Johnson & Johnson on 13 August and the signature of an Advance Purchase Agreement with AstraZeneca on 14 August.

The envisaged contract with CureVac would provide for the possibility for all EU Member States to purchase the vaccine, as well as to donate to lower and middle income countries or re-direct to European countries. It is anticipated that the Commission will have a contractual framework in place for the initial purchase of 225 million doses on behalf of all EU Member States, to be supplied once a vaccine has proven to be safe and effective against COVID-19. The Commission pursues intensive discussions with other vaccine manufacturers.

Our negotiations continue with other companies to find the technology that would protect us all.
Ursula von der Leyen

Ursula von der Leyen President of the European Commission

EU secures Coronavirus Vaccine Deal with AstraZeneca and eudebates with CureVac to expand EU portfolio of future vaccines.

Ursula von der Leyen, President of the European Commission, said: “The European Commission delivers on its promise to secure rapid access for Europeans and the world to a safe vaccine that protects us against the coronavirus. Each round of talks that we conclude with the pharmaceutical industry brings us closer to beating this virus. We will soon have an agreement with CureVac, the innovative European firm that received earlier EU funding to produce a vaccine in Europe. And our negotiations continue with other companies to find the technology that would protect us all“.

We continue to work shoulder to shoulder
Stella Kyriakides

Stella Kyriakides Commissioner for Health

European Vaccines Strategy – A vaccine for all

Stella Kyriakides, Commissioner for Health and Food Safety, said: “Today we concluded talks with the European company CureVac to increase the chances of finding an effective coronavirus vaccine. We continue to work shoulder to shoulder with Member States and with vaccine developers to fulfil the aims of our European Vaccines Strategy – a vaccine for all.”

The exploratory concluded talks are intended to result in an Advance Purchase Agreement to be financed with the Emergency Support Instrument, which has funds dedicated to the creation of a portfolio of potential vaccines with different profiles and produced by different companies.

The CureVac company

CureVac is a European company pioneering the development of a completely new class of vaccines based on messenger RNA (mRNA), transported into cells by lipid nanoparticles. The vaccine platform has been developed over the last decade. The basic principle is the use of this molecule as a data carrier for information, with the help of which the body itself can produce its own active substances to combat various diseases.

On 6 July, the European Investment Bank and CureVac signed a €75 million loan agreement for the development and large-scale production, including CureVac’s vaccine candidate against COVID-19.

The conclusion of the exploratory talks with CureVac is an important step towards the conclusion of an Advance Purchase Agreement, and therefore towards the implementation of the European Vaccines Strategy, adopted by the Commission on 17 June 2020. This Strategy aims to secure high-quality, safe, effective and affordable vaccines for all European citizens within 12 to 18 months. To do so, and together with the Member States, the Commission is agreeing Advance Purchase Agreements with producers reserving or giving the Member States the right to buy a given number of vaccine doses for a certain price, as and when a vaccine becomes available.

No one will be safe until everyone is safe

This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery.

AstraZeneca Deal

European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19 as well as to donate to lower and middle income countries or re-direct to other European countries. This is a positive step following talks with Sanofi-GSK announced on 31 July and with Johnson & Johnson on 13 August. Once it has proven to be safe and effective against COVID-19, the EU now has agreed the basis for a contractual framework for the purchase of 300 million doses of the AstraZeneca, with an option to purchase 100 million more, on behalf of EU Member States.

The European Commission ensures that everyone who needs a vaccine gets it, anywhere in the world and not only at home.

Share this debate with your friends!
Follow #eudebates on Google News and on Facebook
Tags: CoronavirusCOVID19DrugsPresident of the European CommissionPublic HealthStella Kyriakidesthe Future of MedicineUrsula von der LeyenVaccinationVaccinationsVaccines
Share4Tweet3

Related EU debates

Vaccine against COVID-19
Health

WHO chief urges global leaders: ‘Don’t Undermine COVAX’

25/02/2021
Coronavirus test
Health

Fake negative Covid-19 test certificates sold across Europe

23/02/2021
covid-19 doctor
Health

Variants, vaccines and HERA Incubator in Europe

21/02/2021
Exterior of European Medicines Agency in Amsterdam - EMA
Health

EMA preparing guidance to tackle COVID-19 variants

18/02/2021
Vaccination in the EU
Health

COVID-19 global vaccination ‘wildly uneven and unfair’, UN chief warns

17/02/2021
Guy Verhofstadt Member of the European Parliament
Health

Verhofstadt: The inconvenient truth behind the vaccination fiasco in the EU

17/02/2021

Leave a Reply Cancel reply

Your email address will not be published.

European Parliament Plenary MEPs VOTE

MEPS plan to tackle in-work poverty in the EU

25/02/2021
Olivér Várhelyi, on the right, and Eric Mamer, Chief Spokesperson of the European Commission

A new strategic agenda for the Mediterranean

25/02/2021
Forest timber logging

EU and Honduras sign agreement to reduce illegal timber logging

25/02/2021
#HerEducationOurFuture Her education, our future

Two-thirds of poorer countries cut education budgets due to COVID-19

25/02/2021
Vaccine against COVID-19

WHO chief urges global leaders: ‘Don’t Undermine COVAX’

25/02/2021
mobile phone woman GSM coffee

EU wants FREE roaming calls, SMS and data for the next 10 years

24/02/2021
eudebates.tv

Welcome to eudebates.tv the unique european initiative to promote debate, dialogue and communication among citizens for a better Europe.

Follow us on social media:

Recent News

  • MEPS plan to tackle in-work poverty in the EU
  • A new strategic agenda for the Mediterranean
  • EU and Honduras sign agreement to reduce illegal timber logging
  • Two-thirds of poorer countries cut education budgets due to COVID-19
  • WHO chief urges global leaders: ‘Don’t Undermine COVAX’

Newsletter

Join our newsletter!

Enter your email to receive our newsletter.

Don't worry, we don't spam
European Parliament Plenary MEPs VOTE

MEPS plan to tackle in-work poverty in the EU

25/02/2021
Olivér Várhelyi, on the right, and Eric Mamer, Chief Spokesperson of the European Commission

A new strategic agenda for the Mediterranean

25/02/2021
Forest timber logging

EU and Honduras sign agreement to reduce illegal timber logging

25/02/2021
  • Home
  • EU Policies
  • Special Debates
  • Events
  • Vote & Polls
  • Video

© 2021 eudebates - EU debates, dialogue, communication for a better Europe - Privacy Policy.

No Result
View All Result
  • EU Policies
  • World
  • Special Debates
  • Events
  • Vote & Polls

© 2021 eudebates - EU debates, dialogue, communication for a better Europe - Privacy Policy.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist